Valuation Trading Multiples & Precedent Transactions: Retail Pharmacy and Drugstore Chains
Valuation benchmarks for Retail Pharmacy and Drugstore Chains. Access public trading comps, EV/EBITDA acquisition multiples, and private market data for pitch books and valuation analysis.
1.1 - Retail Pharmacy and Drugstore Chains Market Context & Valuation Drivers
Companies in this group operate large retail pharmacy chains that dispense prescriptions and sell over‑the‑counter health, wellness, and personal care products, often augmented by in‑store clinics and digital fulfillment. They are grouped as public trading comparables because they share pharmacy-led, consumer retail business models, similar reimbursement dynamics, and front‑of‑store merchandising economics, yielding comparable revenue mixes, operating leverage, and valuation benchmarks.
Typical capabilities include prescription dispensing across branded and generic drugs, medication therapy management and consultations, over‑the‑counter medicines and health supplements merchandising, traditional Chinese medicine offerings in certain markets, immunizations and basic diagnostic screenings via retail clinics, e‑commerce ordering with home delivery or click‑and‑collect, loyalty programs and merchandising analytics, and, for some operators, wholesale distribution and limited own‑brand manufacturing to support product availability and margin.
Primary customers include consumers and chronic‑care patients purchasing prescriptions and wellness products, healthcare payers and pharmacy benefit managers coordinating reimbursement, and local providers utilizing retail clinics. Valuation benchmarks emphasize prescription volume and script mix, same‑store sales growth, front‑store versus pharmacy gross margin, reimbursement rates and payer mix, store productivity and footprint expansion, digital engagement and customer retention, and EBITDA margin and cash flow conversion.
2. Valuation Analysis: Public Trading Comps & Multiples for Retail Pharmacy and Drugstore Chains companies
2.1 - Public Peer Groups & Median Valuation Multiples for Retail Pharmacy and Drugstore Chains sector
Comparable group 1: Retail Pharmacy and Drugstore Chains
Yifeng Pharmacy
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of precision plastic injection molds and molded parts, specializing in design and manufacturing for automotive, electronics, and appliance industries with a focus on high quality and innovation.
- Key Products:
- Plastic Injection Molding: Offers comprehensive molding solutions for plastics
- Precision Molds: Designs and manufactures high-precision molds for various industries
- Automotive Components: Produces parts tailored for automotive applications
- Electronic Housings: Manufactures durable casings for electronic devices
- Household Appliances Parts: Supplies customized parts for home appliance manufacturers.
DaShenLin Pharmaceutical
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of pharmaceutical products and services, engaging in the development, production, and distribution of medical supplies, focusing on healthcare solutions in both retail and industrial sectors within China.
- Key Products:
- Pharmaceutical Manufacturing: Produces a wide range of medicines including generics and specialized drugs
- Retail Pharmacy Chain: Operates numerous pharmacy outlets offering healthcare products
- Health Consultancy: Provides professional health consultation services at retail locations
- Wholesale Distribution: Supplies medicines and healthcare products to various distributors
- Medical Equipment Sales: Offers a selection of medical devices and health equipment for clinics.